US Biomax, Inc.

T095

Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores

Microarray Panel:Endometrial endometrioid adenocarcinoma test tissue microarray, including 4 cases of endometrium endometrioid adenocarcinoma, 1 each of endometrium endometrial adenosquamous carcinoma and clear cell carcinoma, quadruple cores per case, arranged in 4x small square of array (2x3) for optimizing experimental conditions
Cores:24
Cases:6
Layout:6 cols × 4 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456 
A End End End End End End  
B End End End End End End  
C End End End End End End  
D End End End End End End Marked point
Legend: End - Endometrium

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage IIIc), - Malignant tumor (stage IVa), - Malignant tumor (stage Ic)

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 56 Endometrium Endometrioid adenocarcinoma 1 I T1N0M0 Malignant
A2 2 F 43 Endometrium Endometrioid adenocarcinoma 2 IVa T4N0M0 Malignant
A3 3 F 61 Endometrium Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
A4 4 F 56 Endometrium Endometrioid adenocarcinoma 1 I T1N0M0 Malignant
A5 5 F 43 Endometrium Endometrioid adenocarcinoma 2 IVa T4N0M0 Malignant
A6 6 F 61 Endometrium Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
B1 7 F 51 Endometrium Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
B2 8 F 49 Endometrium Endometrial adenosquamous carcinoma Ic T1cN0M0 Malignant
B3 9 F 47 Endometrium Clear cell carcinoma IIIc T2N1M0 Malignant
B4 10 F 51 Endometrium Endometrioid adenocarcinoma 2–3 Ic T1cN0M0 Malignant
B5 11 F 49 Endometrium Endometrial adenosquamous carcinoma Ic T1cN0M0 Malignant
B6 12 F 47 Endometrium Clear cell carcinoma IIIc T2N1M0 Malignant
C1 13 F 56 Endometrium Endometrioid adenocarcinoma 1 I T1N0M0 Malignant
C2 14 F 43 Endometrium Endometrioid adenocarcinoma 2 IVa T4N0M0 Malignant
C3 15 F 61 Endometrium Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
C4 16 F 56 Endometrium Endometrioid adenocarcinoma 1 I T1N0M0 Malignant
C5 17 F 43 Endometrium Endometrioid adenocarcinoma 2 IVa T4N0M0 Malignant
C6 18 F 61 Endometrium Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
D1 19 F 51 Endometrium Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
D2 20 F 49 Endometrium Endometrial adenosquamous carcinoma Ic T1cN0M0 Malignant
D3 21 F 47 Endometrium Clear cell carcinoma IIIc T2N1M0 Malignant
D4 22 F 51 Endometrium Endometrioid adenocarcinoma 3 Ic T1cN0M0 Malignant
D5 23 F 49 Endometrium Endometrial adenosquamous carcinoma Ic T1cN0M0 Malignant
D6 24 F 47 Endometrium Clear cell carcinoma IIIc T2N1M0 Malignant
F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: